Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2002
03/26/2002CA1341351C Production of chimeric mouse-human antibodies with specificity to human tumor antigens
03/22/2002CA2357526A1 Mannosidase structures
03/21/2002WO2002023561A1 Electromagnetic device and high-voltage generating device and method of producing electromagnetic device
03/21/2002WO2002023202A2 Method to identify antibody targets based on mass spectrometry (maldi-tof)
03/21/2002WO2002023184A1 Method for treatment of insulin resistance in obesity and diabetes
03/21/2002WO2002022890A2 Compositions, methods and kits for determining the presence of cryptosporidium organisms in a test sample
03/21/2002WO2002022885A1 Compositions and methods for identifying and targeting stomach and esophageal cancer cells
03/21/2002WO2002022884A2 Microarrayed organization of transcription factor target genes
03/21/2002WO2002022883A1 Combinatorial fluorescence energy transfer tags and uses thereof
03/21/2002WO2002022882A2 Target activated nucleic acid biosensor and methods of using same
03/21/2002WO2002022880A1 Compositions and methods for the identification of viral inhibitors of host cell protein synthesis shut-off
03/21/2002WO2002022879A2 Detection of microsatellite instability and its use in diagnosis of tumors
03/21/2002WO2002022878A1 Microfluidic devices and methods for performing temperature mediated reactions
03/21/2002WO2002022876A1 Method of identifying putative antibiotic resistance genes
03/21/2002WO2002022874A2 Oligonucleotides for labeling oligonucleotide probes and proteins
03/21/2002WO2002022873A1 Method and kit for determining human geographic or population origin
03/21/2002WO2002022871A2 Polymorphic bone morphogenetic protein 2
03/21/2002WO2002022869A2 Directed evolution method
03/21/2002WO2002022866A2 Method and sampling kit for analysing material containing nucleic acid
03/21/2002WO2002022864A1 The method of detecting mutant dspp gene of hereditary opalescent
03/21/2002WO2002022861A1 Oxygenase enzymes and screening method
03/21/2002WO2002022843A2 Nucleotide sequences which code for the dep34 gene
03/21/2002WO2002022840A1 Antisense modulation of madh6 expression
03/21/2002WO2002022839A2 Internal ribosome entry sites (ires) of errantiviruses and uses thereof
03/21/2002WO2002022838A2 Transgenic poa grasses
03/21/2002WO2002022837A2 Identification and characterization of a dwarf and late flowering 2 phenotype (dlf2) in arabidopsis
03/21/2002WO2002022836A2 A method for producing plants which are resistant to closteroviruses
03/21/2002WO2002022835A2 Targeted genetic manipulation using mu bacteriophage cleaved donor complex
03/21/2002WO2002022834A2 Methods of producing cells and animals comprising targeted gene modifications
03/21/2002WO2002022832A1 A cell line expressing mutated human tissue - type plasminogen activator, the constructing strategy thereof and method of preparing expressed protein
03/21/2002WO2002022831A1 Thermotolerant ribonuclease h
03/21/2002WO2002022830A2 Transglutaminase gene products
03/21/2002WO2002022829A2 Nucleotide sequences which code for the ppsa gene
03/21/2002WO2002022828A1 Isolation and sequencing of the pknb gene of c. glutamicum
03/21/2002WO2002022827A1 Isolation and sequences of the ptsi gene of c. glutamicum
03/21/2002WO2002022826A2 Methods and compositions for the construction and use of fusion libraries
03/21/2002WO2002022825A2 The c. albicans tec1 gene (catec1) and the coded tec1p protein
03/21/2002WO2002022824A2 Ashbya gossypii genes coding for proteins involved in membrane transport
03/21/2002WO2002022823A2 Proteins involved in the stress response and genes from ashbya gossypii coding for the same
03/21/2002WO2002022822A2 Plant derived bag homologues
03/21/2002WO2002022821A2 Antimicrobial peptides and methods of use
03/21/2002WO2002022820A1 Inhibition of stenosis or restenosis by p-selectin antagonists
03/21/2002WO2002022819A2 Calcium binding proteins
03/21/2002WO2002022818A1 Human and rat pgc-3, ppar-gamma coactivations and splice variants thereof
03/21/2002WO2002022817A2 Nuclear receptor l66 and methods of use
03/21/2002WO2002022816A1 A novel polypeptide- estrogen receptor related protein 14.19 and the polynucleotide encoding said polypeptide
03/21/2002WO2002022815A1 Methods and materials relating to neuropilin-like polypeptides and polynucleotides
03/21/2002WO2002022814A2 Nucleotide sequences which code for the atr43 gene
03/21/2002WO2002022811A2 Modulation of meiotic recombination
03/21/2002WO2002022810A2 Combinatorial screening of mixed populations of organisms
03/21/2002WO2002022809A2 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
03/21/2002WO2002022808A2 Cripto mutant and uses thereof
03/21/2002WO2002022807A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof
03/21/2002WO2002022806A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof
03/21/2002WO2002022805A2 Modulation of il-2- and il-15-mediated t cell responses
03/21/2002WO2002022804A2 Compositions and methods for stable transformation using mu bacteriophage cleaved donor complex
03/21/2002WO2002022802A1 Novel compounds
03/21/2002WO2002022801A2 Mammalian receptor genes and uses
03/21/2002WO2002022800A2 Expression cassettes and adenovirus vectors
03/21/2002WO2002022799A2 Method for the microbial production of metabolic products, polynucleotides from coryneform bacteria and use thereof
03/21/2002WO2002022798A2 Modulation of homologous recombination with single stranded dna binding proteins
03/21/2002WO2002022796A1 Calcium free subtilisin mutants
03/21/2002WO2002022795A2 Isolated human kinase proteins, nucleic acid molecules and uses thereof
03/21/2002WO2002022791A2 Regulation of human pyridoxine 5'-phosphate oxidase
03/21/2002WO2002022786A1 Method and cell composition for screening compounds for anti-inflammatory activity
03/21/2002WO2002022783A2 Liver gene expression associated with the inhibition of hbv replication or transcription
03/21/2002WO2002022782A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
03/21/2002WO2002022779A2 High level expression of heterologous proteins
03/21/2002WO2002022778A2 Ab initio physics-based gene identification method
03/21/2002WO2002022777A2 Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses
03/21/2002WO2002022776A2 Human coagulation factor vii variants
03/21/2002WO2002022685A2 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom
03/21/2002WO2002022684A2 Transporters and ion channels
03/21/2002WO2002022683A1 Novel dendritic cell wall membrane and use thereof
03/21/2002WO2002022682A1 Interferon-alpha induced gene
03/21/2002WO2002022681A2 Neuronally expressed protein and use thereof
03/21/2002WO2002022680A2 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine)
03/21/2002WO2002022679A2 Variants of phleum pratense allergenic proteins
03/21/2002WO2002022678A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/21/2002WO2002022677A2 Variants of allergenic proteins of the group 2 of dermatophagoides
03/21/2002WO2002022676A1 A longevity guarantee protein and its encoding sequence and use
03/21/2002WO2002022675A2 Plant genes, the expression of which are altered by pathogen infection
03/21/2002WO2002022667A2 Twin-arginine translocation in bacillus
03/21/2002WO2002022665A1 Novel g protein-coupled receptor proteins and dnas tehreof
03/21/2002WO2002022664A2 Antigenic proteins of shrimp white spot syndrome virus and uses thereof
03/21/2002WO2002022663A2 Stress resistant retroviruses
03/21/2002WO2002022662A2 Insect inhibitory bacillus thuringiensis proteins, fusions, and methods of use therefor
03/21/2002WO2002022661A2 NOVEL PDEs AND USES THEREOF
03/21/2002WO2002022660A2 Novel nucleic acids and polypeptides
03/21/2002WO2002022648A2 Compositions and methods for inducing specific cytolytic t cell responses
03/21/2002WO2002022642A1 Antisense insulin-like growth factor binding protein (igfbp)-2-oligodeoxynucleotides for prostate and other endocrine tumor therapy
03/21/2002WO2002022641A1 Antisense modulation of caspase 9 expression
03/21/2002WO2002022640A1 Antisense modulation of caspase 7 expression
03/21/2002WO2002022639A1 Antisense modulation of btak expression
03/21/2002WO2002022637A1 Antisense modulation of phosphorylase kinase beta expression
03/21/2002WO2002022636A1 Antisense modulation of her-2 expression
03/21/2002WO2002022635A1 Antisense modulation of clusterin expression
03/21/2002WO2002022633A2 Nucleotide sequences which code for the atr61 gene
03/21/2002WO2002022632A2 Nucleotide sequences coding for the pknd gene
03/21/2002WO2002022631A2 Regulation of human pyroglutamyl peptidase-like enzyme
1 ... 2853 2854 2855 2856 2857 2858 2859 2860 2861 2862 2863 2864 2865 2866 2867 2868 2869 2870 2871 2872 2873 ... 4023